ETRADE Capital Management LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
ETRADE Capital Management LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2018$208,000
-64.1%
2,697
-65.6%
0.01%
-66.7%
Q2 2018$580,000
+5.6%
7,851
-7.0%
0.02%0.0%
Q1 2018$549,000
-4.4%
8,440
-5.1%
0.02%0.0%
Q4 2017$574,000
+4.0%
8,892
+1.0%
0.02%
-10.0%
Q3 2017$552,000
+3.8%
8,804
+0.3%
0.02%
-4.8%
Q2 2017$532,000
+100.8%
8,782
+71.9%
0.02%
+90.9%
Q1 2017$265,000
-73.3%
5,108
-83.1%
0.01%
-82.0%
Q3 2015$992,000
-67.5%
30,190
-30.9%
0.06%
-65.9%
Q2 2015$3,053,000
+5.1%
43,660
+2.9%
0.18%
+3.5%
Q1 2015$2,906,000
-3.8%
42,424
+2.9%
0.17%
-6.0%
Q4 2014$3,022,000
+5.7%
41,233
+3.5%
0.18%
-1.1%
Q3 2014$2,860,000
-5.7%
39,853
-5.0%
0.19%
-7.9%
Q2 2014$3,034,000
+5.4%
41,969
+7.2%
0.20%
-1.9%
Q1 2014$2,879,000
+28.3%
39,133
+21.3%
0.21%
+16.4%
Q4 2013$2,244,000
+201.2%
32,261
+184.3%
0.18%
+160.3%
Q3 2013$745,000
+21.5%
11,348
+28.3%
0.07%
+4.6%
Q2 2013$613,0008,8450.06%
Other shareholders
BAXTER INTL INC shareholders Q3 2018
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders